Atlas Trials

Trial of Stereotactic Body Radiotherapy With Concurrent Pembrolizumab in Metastatic Urothelial Cancer

Clinical trial NCT02826564 · COMPLETED

Trial details

NCT number
NCT02826564
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Urothelial Cancer
Start date
2016-11-14
Primary completion
2018-04-02
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.